3ROZET I.Methylprednisolone in acute spinal cord in jury is there any other ethical choice[J].J Neurosurg Anesthesiol,2008,20(2):137-139. 被引量：1
4QIAN T,GUO X,LEVI A D,et al.High-dose methylprednisolone may cause myopathy in acute spinal cord injury patients[J].Spinal Cord,2005,43(4):199-203. 被引量：1
5MEROLA A,O′BRIEN M F,CASTRO B A.Histologic characterization of acute spinal cord injury treated with intravenous ethylprednisolone[J].J Orthop Trauma,2002,16(3):155-161. 被引量：1
6DALEY YATES P T,GREGORY A J,BROOKS C D.Pharmacokinetic and pharmacodynamic assessment of bioavailability for two drugs of methylprednisolone[J].Br J Clin Pharmacol,1997,43(6):593-601. 被引量：1
7HARBERT R J.The role of steroids in acute spinal cord injury:an evidence based analysis[J].Spine,2001,26(Suppl 1):S39-S46. 被引量：1
8SUBERVIOLA B,GONZLEZ CASTRO A,LLORCA J,et al.Early complications of high-dose methylprednisolone in acute spinal cord injury patients[J].Injury,2008,39(7):748-752. 被引量：1
9HURLBERT R J,HAMILTON M G.Methylprednisolone for acute spinal cord injury:5-year practice reversal[J].Can J Neurol Sci,2008,35(1):41-45. 被引量：1
10POINTILLART V,PETITJEAN M E,WIART L,et al.Pharmacological therapy of spinal cord injury during the acute phase[J].Spinal Cord,2000,38(2):71-76. 被引量：1
